PRMT5 and lymphoma: We hypothesized that the resistance to GSK-591 observed in some lymphoma cell lines and the modest effect of PRMT5 inhibitor in vivo are likely related to the induction of feedback survival mechanisms and/or due to the coexistence of parallel survival pathways.